CVAC logo

CureVac N.V. (CVAC)

Profile

Full Name

CureVac N.V.

Ticker

NASDAQ: CVAC

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

Germany

IPO

August 14, 2020

Indexes

Not included

Website

http://www.curevac.com

Employees

825

Key Details

Price

$5.46(+0.37%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$579.25M(+895.30% YoY)

Annual EPS

$0.78(+161.00% YoY)

PE ratio

6.05

Next earnings date

Aug 15, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $5.46
    CVAC price is $5.46

    30-Day Relative Volume

    0.31
    CVAC 30-day relative volume is 0.31

    Price Performance

    Price Most recent change

    +0.37%
    CVAC price was up +0.37% on Jul 25, 2025

    Price YTD change

    +60.12%
    CVAC price is up +60.12% since January 1st

    Price 1-year change

    +50%
    CVAC price is up +50% year-on-year

    Price 3-year change

    -59.47%
    CVAC price is down -59.47% over the past 3 years

    Price Range

    Price All-time high

    $151.80
    CVAC price is currently -96.40% below its historical high of $151.80

    Price 3-year low

    $2.21
    CVAC price is currently +146.50% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $1.23B
    CVAC market capitalization is $1.23 billion

    Market cap 3-year change

    -51.32%
    CVAC market capitalization is down -51.32% over the past 3 years

    Market cap All-time high

    $24.58B
    CVAC market capitalization is currently -95.00% below its historical high of $24.58 billion

    Market cap sector rank

    76.92%
    CVAC market capitalization is higher than 76.92% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +0.38%
    CVAC shares outstanding is up +0.38% year-on-year

    Shares Outstanding 3-Year Change

    +20.11%
    CVAC shares outstanding is up +20.11% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    1.10
    CVAC beta is 1.10

    200-day SMA

    $3.63
    CVAC price is currently +50.62% above its 200-day simple moving average

    50-day SMA

    $4.95
    CVAC price is currently +10.29% above its 50-day simple moving average

    RSI

    61.13
    CVAC 14-day relative strength index is 61.13

    Volume

    0.31
    CVAC 30-day relative volume is 0.31

    ATR

    $0.09
    CVAC average true range is $0.09

    10-day Historical Volatility

    12.53%
    CVAC 10-day historical volatility is 12.53%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $579.25M
    CVAC annual revenue is $579.25 million

    Revenue Analysts estimate

    $69.05M
    CVAC annual revenue is currently +738.88% higher than the consensus analysts' forecast

    Revenue 1-year change

    +895.3%
    CVAC annual revenue is up +895.3% year-on-year

    Revenue Sector rank

    74.74%
    CVAC annual revenue is higher than 74.74% of companies in Healthcare sector

    EPS

    EPS

    $0.78
    CVAC annual earnings per share is $0.78

    EPS Analysts estimate

    -$0.49
    CVAC annual earnings per share is currently -260.05% lower than the consensus analysts' forecast

    EPS 1-year change

    +161%
    CVAC annual earnings per share is up +161% year-on-year

    EPS Sector rank

    88.3%
    CVAC annual earnings per share is higher than 88.3% of companies in Healthcare sector

    Profit

    Gross profit

    $464.71M
    CVAC annual gross profit is $464.71 million

    Gross margin

    80.23%
    CVAC annual gross profit margin is 80.23%

    Operating profit

    $192.31M
    CVAC annual operating income is $192.31 million

    Operating margin

    33.20%
    CVAC annual operating profit margin is 33.20%

    Net income

    $175.54M
    CVAC annual net profit is $175.54 million

    Net margin

    30.30%
    CVAC annual net profit margin is 30.30%

    Expenses

    Total expenses

    $386.94M
    CVAC annual total expenses is $386.94 million

    Operating expenses

    $272.39M
    CVAC annual total operating expenses is $272.39 million

    Cost of goods sold

    $114.54M
    CVAC annual cost of goods sold is $114.54 million

    Selling, general & administrative expenses

    $65.83M
    CVAC annual SGA is $65.83 million

    Depreciation and amortization

    $20.36M
    CVAC annual depreciation & amortization is $20.36 million

    Interest expense

    $0.00
    CVAC annual interest expense is $0.00

    Income tax

    $31.06M
    CVAC annual income tax is $31.06 million

    EBIT & EBITDA

    EBIT

    $206.60M
    CVAC annual earnings before interest & taxes is $206.60 million

    EBITDA

    $226.96M
    CVAC annual EBITDA is $226.96 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $835.40M
    CVAC annual total assets is $835.40 million

    Non current assets

    $287.63M
    CVAC annual long term assets is $287.63 million

    Current assets

    $547.77M
    CVAC annual total current assets is $547.77 million

    Cash and cash equivalents

    $501.29M
    CVAC annual cash & cash equivalents is $501.29 million

    Accounts receivable

    $14.65M
    CVAC annual accounts receivable is $14.65 million

    Inventory

    $562.90K
    CVAC annual inventory is $562.90 thousand

    Liabilities

    Total liabilities

    $110.53M
    CVAC annual total liabilities is $110.53 million

    Long term liabilities

    $35.25M
    CVAC annual total long term liabilities is $35.25 million

    Current liabilities

    $75.28M
    CVAC annual total current liabilities is $75.28 million

    Accounts payable

    $17.97M
    CVAC annual accounts payable is $17.97 million

    Debt

    Total debt

    $40.55M
    CVAC annual total debt is $40.55 million

    Total debt 1-year change

    -12.3%
    CVAC annual total debt is down -12.3% year-on-year

    Long term debt

    $35.01M
    CVAC annual long term debt is $35.01 million

    Short term debt

    $5.54M
    CVAC annual short term debt is $5.54 million

    Equity & Capital

    Shareholders equity

    $724.87M
    CVAC annual stockholders equity is $724.87 million

    Book value

    $724.87M
    CVAC annual book value is $724.87 million

    Retained earnings

    -$1.46B
    CVAC annual retained earnings is -$1.46 billion

    Working capital

    $472.49M
    CVAC annual working capital is $472.49 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    $110.24M
    CVAC annual cash flow from operations is $110.24 million

    Cash from operations 1-year change

    +138.01%
    CVAC annual cash flow from operations is up +138.01% year-on-year

    Cash from investing

    -$19.96M
    CVAC annual cash flow from investing activities is -$19.96 million

    Cash from investing 1-year change

    +66.59%
    CVAC annual cash flow from investing activities is up +66.59% year-on-year

    Cash from financing

    -$5.54M
    CVAC annual cash flow from financing activities is -$5.54 million

    Cash from financing 1-year change

    -102.21%
    CVAC annual cash flow from financing activities is down -102.21% year-on-year

    CAPEX

    CAPEX

    $19.96M
    CVAC annual capital expenditures is $19.96 million

    CAPEX 1-year change

    -66.59%
    CVAC annual capital expenditures is down -66.59% year-on-year

    Free Cash Flow

    Free cash flow

    $90.28M
    CVAC annual free cash flow is $90.28 million

    Free cash flow 1-year change

    +125.81%
    CVAC annual free cash flow is up +125.81% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    80.23%
    CVAC annual gross profit margin is 80.23%

    Operating margin

    33.20%
    CVAC annual operating profit margin is 33.20%

    Net margin

    30.30%
    CVAC annual net profit margin is 30.30%

    ROA & ROE

    ROA

    20.57%
    CVAC annual return on assets is 20.57%

    ROE

    27.08%
    CVAC annual return on equity is 27.08%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    6.05
    CVAC price to earnings ratio is 6.05

    PE ratio Sector rank

    9.43%
    CVAC price to earnings ratio is higher than 9.43% of companies in Healthcare sector

    PB Ratio

    PB ratio

    1.76
    CVAC price to book ratio is 1.76

    PB ratio Sector rank

    50.87%
    CVAC price to book ratio is higher than 50.87% of companies in Healthcare sector

    PS Ratio

    PS ratio

    2.14
    CVAC price to sales ratio is 2.14

    PS ratio Sector rank

    39.6%
    CVAC price to sales ratio is higher than 39.6% of companies in Healthcare sector

    Enterprise value

    Enterprise value

    $795.41M
    CVAC enterprise value is $795.41 million

    Enterprise value Sector rank

    71.81%
    CVAC enterprise value is higher than 71.81% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    3.12
    CVAC EV/EBITDA is 3.12

    EV/EBITDA Sector rank

    77.11%
    CVAC EV/EBITDA is higher than 77.11% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    7.28
    CVAC annual current ratio is 7.28

    Quick ratio

    7.27
    CVAC annual quick ratio is 7.27

    Leverage

    Debt to equity

    0.00
    CVAC annual debt to equity ratio is 0.00

    Interest coverage ratio

    -
    CVAC annual interest coverage ratio value is unknown

    Risk & Stability

    Piotroski F-Score

    7
    CVAC piotroski f-score is 7

    Altman Z-Score

    6.41
    CVAC altman z-score is 6.41

    Analyst ratings

    Recent major analysts updates

    Jun 26, 25 UBS
    Neutral
    Jun 13, 25 Jefferies
    Hold
    May 28, 25 JMP Securities
    Market Outperform
    Apr 30, 25 UBS
    Buy
    Feb 14, 25 JMP Securities
    Market Outperform
    Sep 16, 24 JMP Securities
    Market Outperform
    Aug 16, 24 JMP Securities
    Market Outperform
    Jul 3, 24 JMP Securities
    Market Outperform
    Apr 25, 24 Leerink Partners
    Market Perform
    Apr 5, 24 Guggenheim
    Neutral

    Institutional Ownership

    Screeners with CVAC included

    Growing Shares Outstanding
    High Piotroski score stocks
    Stocks with high beta
    Best performing stocks last 3 months
    NASDAQ Dividend Calendar
    Stocks above SMA 50
    Stocks ready to break out
    Healthcare sector
    All stocks
    High Altman Z score stocks
    • What is the ticker symbol for CureVac N.V.?
    • Does CureVac N.V. pay dividends?
    • What sector is CureVac N.V. in?
    • What industry is CureVac N.V. in?
    • What country is CureVac N.V. based in?
    • When did CureVac N.V. go public?
    • Is CureVac N.V. in the S&P 500?
    • Is CureVac N.V. in the NASDAQ 100?
    • Is CureVac N.V. in the Dow Jones?
    • When was CureVac N.V.'s last earnings report?
    • When does CureVac N.V. report earnings?

    What is the ticker symbol for CureVac N.V.?

    The ticker symbol for CureVac N.V. is NASDAQ:CVAC

    Does CureVac N.V. pay dividends?

    No, CureVac N.V. does not pay dividends

    What sector is CureVac N.V. in?

    CureVac N.V. is in the Healthcare sector

    What industry is CureVac N.V. in?

    CureVac N.V. is in the Biotechnology industry

    What country is CureVac N.V. based in?

    CureVac N.V. is headquartered in Germany

    When did CureVac N.V. go public?

    CureVac N.V.'s initial public offering (IPO) was on August 14, 2020

    Is CureVac N.V. in the S&P 500?

    No, CureVac N.V. is not included in the S&P 500 index

    Is CureVac N.V. in the NASDAQ 100?

    No, CureVac N.V. is not included in the NASDAQ 100 index

    Is CureVac N.V. in the Dow Jones?

    No, CureVac N.V. is not included in the Dow Jones index

    When was CureVac N.V.'s last earnings report?

    CureVac N.V.'s most recent earnings report was on May 20, 2025

    When does CureVac N.V. report earnings?

    The next expected earnings date for CureVac N.V. is August 15, 2025
    On this page